Interview: UK Initiative Bids To Boost Access To Cancer Clinical Trials
Fewer Than 50% Of Patients Told About Trials After Cancer Diagnosis
Executive Summary
The Christie cancer hospital in Manchester has linked up with Innovative Trials to try and get more minority and socially-deprived communities into clinical studies.
You may also be interested in...
Expanding The Tent: Improving Trial Participation Among Under-Represented Patient Populations
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.